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Abstract
Background: Effects of depression on parenting and on cognitive development of newborns are augmented
when symptoms continue throughout the first postnatal year. Current classification systems recognize maternal
depression as postnatal if symptoms commence within four to six weeks. Traditional cultural rituals in Sudan offer
new mothers adequate family support in the first 6–8 weeks postpartum. The course of postnatal depression
symptoms beyond that period is not explored in such settings. We therefore aim to investigate the change in
screening status and in severity of depression and distress symptoms between three and eight months postpartum
among a sample of Sudanese women using the Edinburgh Postnatal Depression Scale (EPDS) and a locally used tool:
the 10-items Hopkins Symptoms Checklist (HSCL-10).
Methods: Three hundred pregnant women in their 2nd or 3rd trimester were recruited from two clinics in Khartoum
state. They were followed up and screened for depression symptoms eight months after delivery by EPDS at ≥12, and
by HSCL-10 at ≥1.85. The same sample was previously screened for depression at three months after birth.
Results: Prevalence of postnatal depression symptoms by EPDS was lower at eight months compared to three
months after birth (3.6% at eight months (8/223) compared to 9.2% at three months (22/238), p < 0.001). Eight
Mothers exhibited depression symptoms eight months after birth. Depressed mothers at three months had a 56%
reduction in EPDS mean scores by eight months and 96.4% of participants either remained in the same EPDS
category, or improved eight months after birth. Four participants with major depression symptoms at eight months
were also depressed three months after birth and four participants had new onset depression symptoms. The HSCL-10
measured higher distress than EPDS across the two screening points (19.3% at three months, 9.1% at eight months
postpartum, p < 0.001). Nonetheless, the two tests correlated positively at both points.
Conclusions: Repeated screenings by EPDS (depression surveillance) is recommended during the first postnatal year
because a subset of mothers can have symptoms beyond the early postnatal period. Existing depression screening
instruments can be assessed for their validity to detect PND.
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Background
Depression is classified as postnatal depression (PND) by the
10th revision of the International Statistical Classification of
Diseases and Related Health Problems (ICD-10) if symptoms
occur within the first six weeks after birth, and by the Diag-
nostic and Statistical manual for Mental Disorders (DSM) if
symptoms occur within the first four weeks after birth [1, 2].
Postnatal depression affects a mother’s capacity to form and
maintain attachment with her newborn increasing the risk of
attachment disorders during infancy and childhood [3]. Com-
pared to a previous report by the World Health Organization
(WHO) on PND in low and lower middle income countries
(LLMIC) [4], recent reviews on prevalence of postnatal de-
pression show higher estimates. Norhayati et al. [5] reported
from LLMIC, based on screening results by the Edinburgh
Postnatal Depression Scale (EPDS), prevalence estimates ran-
ging from 12.9 to 50.7% at less than four weeks screening,
4.9–50.8% at four to eight weeks, 8.2–38.2% at six months
after birth and 21.0–33.2% in the first postnatal year.
Prolonged postnatal depression is linked to maternal
morbidity and to poor childhood cognitive and behav-
ioral development [6]. Minkovitz et al. [7] followed chil-
dren in the US up to age three and reported that
mothers diagnosed with postnatal depression accessed
well-baby and immunization visits at a lesser rate than
mothers without depression, and they utilized emer-
gency services for their infants at a higher rate. A
16 months US follow-up study on infant and maternal
health-related quality of life by Darcy et al. [8] reported
that maternal depressive symptoms at four months after
birth predicted poorer infant health at 8, 12 and
16 months assessments. O’Brian et al. [9] examined two
years old children in the UK and reported that those
with faltering growth are more likely to have depressed
mothers than children who are gaining weight
appropriately. These findings elucidate the risk of con-
tinuing or “chronic depression” on health of children
due to longer periods of maternal negative affects. The
well-documented evidence on impact of PND on the
quality of life of both mother and child makes it logical
to identify and treat it. Wickramaratne et al. [10] re-
ported that early remission of maternal depression leads
to improvement in all child outcomes.
Many health systems worldwide advocate for universal
screening for postnatal depression to increase detection
rate, but the optimum time for screening or the fre-
quency of screening needed during the postnatal period
is still unclear. This issue has been raised by few scholars
[11–13]. The DSM 4 and 5, as well as the ICD-10, do
not classify late onset postnatal depression [2, 14]. For
that reason, exploration of the course of depressive
symptoms after birth has become paramount.
A number of systematic reviews and longitudinal stud-
ies illustrated the course of depression symptoms after
birth. Halbreich and Karkun [15] reviewed studies from
high and low income countries. They showed that higher
estimates of depression prevalence are commonly no-
ticed during periods closer to birth than periods further
away when brief instruments are used for screening,
mostly EPDS [15]. Goodman’s [16] study reviewed PND
beyond the early postnatal period (from 6 months up to
2 1/2 years after delivery) in high-income countries and
reported that a significant proportion of mothers con-
tinue with depressive symptoms for months and years
after giving birth. Vliegen et al. [17] reported on seven
longitudinal studies that followed mothers up to three
years after birth in high-income countries. The review
showed a general reduction in severity of depression
symptoms throughout pregnancy and the postnatal
period, but not all reductions were statistically signifi-
cant [17]. They also reported prevalence estimates from
20 longitudinal studies on community-based and clinical
samples. They concluded that 30% of depressed mothers
from community samples and 50% of depressed mothers
from clinical samples remain depressed throughout and
beyond the first postnatal year [17].
Studies from the US also reported continued symp-
toms of depression one and two years after birth [18,
19]. A study from Pakistan recruited 701 mothers during
their third trimester of pregnancy and assessed them for
depression at 3, 6 and 12 months after birth [20].
Fifty-six percent of mothers that completed follow-up
exhibited depression symptoms at all points of assess-
ment [20].
We have previously reported on the three months
prevalence of PND symptoms using the EPDS [21]. We
have little knowledge on how postnatal depressive symp-
toms evolve in a North African context: how many cases
have a more prolonged course and will new cases appear
after the three months period? In addition, will those
new cases be “normal” depressive episodes or late post-
natal depression? There is also a need to find out if other
screening instruments for depressive symptoms used lo-
cally are useful in the detection of symptoms in the post-
natal period.
The objective of this article is to investigate the course
of depressive symptoms up to eight months after birth
in a Sudanese sample using the Edinburgh Postnatal De-
pression Scale (EPDS). In addition, we want to explore
correlations between the EPDS and a locally used tool
for screening for depression outside pregnancy: the
10-items Hopkins Symptoms Checklist (HSCL-10)
points.
Methods
Study design
This is a follow-up study of 300 women recruited during
pregnancy. Women attending two antenatal clinics
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(ANC) in two major public tertiary hospitals consented
to participate in the study. They were screened for
symptoms of postnatal depression at three and eight
months by EPDS and HSCL-10. The clinics provide rou-
tine antenatal care services for pregnant women living
within or outside the hospitals’ catchment population.
The hospitals were Omdurman Maternity Teaching
Hospital and Ibrahim Malik Teaching Hospital. Com-
pared to other states in Sudan, Khartoum state has the
highest level of utilization of ANC services and the high-
est level of institutional deliveries as well [22]. Antenatal
care attendance in Khartoum state is 88% [22]. This is
the proportion of women that attend “at least one” ANC
visit provided by a skilled provider. Women from all lo-
calities of Khartoum state can access services in Omdur-
man Maternity Hospital irrespective of their residence
[23]. The sample size was calculated using the preva-
lence of PND in Nigeria, an African country with a simi-
lar social context to Sudan [24]. Inclusion criteria were
women of Sudanese nationality, in their 2nd or 3rd tri-
mester, of any parity and with full contact information
(at least two working telephone numbers). Availability of
two working phone numbers was imperative to improve
follow-up rates through house visits, as the address
system in that context was unclear. Illiteracy was not an
exclusion criterion as data collection was via interviews.
The study protocol was approved in Sudan by the Sudan
Ministry of Health and in Norway by REK (Regional
Committees for Medical and Health Research Ethics,
reference no. 2013/353/REK).
Study procedure
Recruitment was intermittent during the period of April
2013 until April 2014. More than 5000 women attended
the clinics during that period; the principle investigator
approached approximately 700 women. The attending
physician screened attendants for the required gesta-
tional age and introduced the investigator to each pro-
spective participant at the end of her ANC visit.
Random sampling from a list of ANC attendees was not
possible in that setting. Approximately four hundred
women were not included: almost two hundred women
refused to be part of a research study and the remaining
were excluded due to none eligibility because they had
no telephone number. No information was available of
those who refused participation. Recruitment continued
during that period until 300 women consented to
participate in the study. They were interviewed at re-
cruitment (T0), and screened at three months (T1) and
eight months postpartum (T2). Figure 1 illustrates the
follow-up process.
First interview (T0, n = 300)
Full contact information was obtained at recruitment to
optimize follow-up and screening rate for PND after de-
livery. Median age of women at recruitment was 28 years
Fig. 1 A flow chart illustrating the follow-up process
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(range 15 to 43); 41% were between the ages of 15–25.
Twelve percent held an occupation. The majority (215
women) had no previous employment (72%), 10% (31
women) had an occupation before marriage or child-
birth, and 6% (17 women) were students. [21]
Second interview (first screening) (T1, n = 238)
At three months postpartum, participants were inter-
viewed regarding circumstances of the index pregnancy.
The interview was either face-to-face (at home or ANC
clinic), or through phone. Phone interviews were con-
ducted to minimize loss of follow-up only when women
were away from Khartoum state or refused home inter-
views. The first EPDS and HSCL-10 screening was con-
ducted at that time. A single interviewer conducted the
interviews. As reported from a previous analysis in the
same study [21], the response rate at T1 was 79.3% (62
participants were lost to follow-up). The loss to
follow-up was due to personal refusal (14 participants),
husband’s refusal (13 participants), and contact failure
(35 participants). Participants lost to follow-up were not
significantly different from participants who completed
the follow-up in age (the median age was 27 years old
for both groups), in parity (the median parity was 1.9
children and 1.8 children, respectively) or in educational
level (Pearson chi-square p-value = 0.70) [21].
Third interview (second screening) (T2, n = 243)
At eight months postpartum, 243 women were screened
for PND with EPDS and HSCL-10 resulting in a
follow-up rate of 81%. Fifty-seven women were lost in
the second screening due to contact failure (27 partici-
pants), personal refusal (15 participants), and husband
refusal (15 participants).
Measurement tools
EPDS
The Edinburgh Postnatal Depression Scale (EPDS) is a
self-reporting tool specifically developed for screening
for symptoms of postnatal depression at primary health-
care level [25]. It has been translated and validated into
57 languages including Arabic [26–28]. We have vali-
dated the Arabic EPDS in this sample and we have de-
scribed its validity indices against a diagnostic tool [21].
The EPDS screens for PND through ten inventory ques-
tions investigating new feelings felt by the mother within
the previous seven days. Each question has four possible
answers rated from 0 to 3 and the scale has a total score
of 30. In this study, EPDS was administered through per-
sonal interviews and a test is “positive” for major depres-
sion if the woman scores 12 or more out of 30 as set by
Cox et al. [25]. A cut-off point of ≥10 is optimum for
screening for minor and major depression combined
[25]. Combined subscale analysis of EPDS confirms that
there is an anxiety scale embedded within the tool and
that the whole 10 item tool measures both depression
and anxiety [29].
Although it is a self-administered tool, studies have
shown that administering EPDS through directed inter-
views is an equivalent screening technique [30]. Accord-
ing to Ghubash et al. [27], the Arabic EPDS has good
internal consistency and reliability with a Cronbach’s co-
efficient of 0.84. In the current study, the Cronbach’s co-
efficient was 0.83.
Prevalence of PND symptoms at T1 with the EPDS at
≥12 was 9.2% [21]. Validity indices of the EPDS were 89%
sensitivity, 82% specificity, 98.7% NPV and 33% PPV [21].
Only a subsample of participants was clinically inter-
viewed for assessment of their depression symptoms
(the EPDS “test positives” at T1 and their matched con-
trols). Clinically depressed participants were referred to
the outpatient mental health clinic in Khartoum for fur-
ther management.
HSCL-10
Originally the Hopkins Symptoms Checklist was a
58-item self-reporting inventory symptom checklist de-
veloped in the mid-1970s for psychological distress [31].
A ten items version as well as 35, 25 and five items ver-
sions were also developed and validated against the ex-
tended version and were found of equal performance
[32, 33]. The first four items in the 10-item tool evaluate
“anxiety” and the remaining six items “depression”. Each
item has a 4-point scale ranging from “not at all” to “ex-
tremely”. The symptoms screened were in the seven days
prior to screening. HSCL-10 final score is the average of
the total score. The cut-off score for “distress” used in
this study is ≥1.85 [32]. It has been translated to Arabic
and validated on Arab speaking populations [34].
HSCL-10 is brief and simple. It has well-documented re-
liability and validity and is an easily administered instru-
ment. In this analysis, it has an acceptable internal
consistency of 0.77.
Statistical analysis
Prevalence of major depression symptoms at eight
months postpartum (T2) was calculated based on EPDS
at a cut-off point ≥12/30. The prevalence of depression
symptoms at T1 and T2 with EPDS at a cut-off score ≥
10/30 was also explored (reflecting prevalence of major
and minor depression combined).
Prevalence of psychological distress with HSCL-10 at
three months (T1) and eight months (T2) postpartum
was calculated at a cut-off point ≥1.85. Correlation coef-
ficients among scores of the two tests were computed.
Numbers of new and continuous depression symptoms
between the two screening points, based on EPDS, were
calculated. The change in EPDS test status between T1
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to T2 was analysed for its statistical significance (i.e. if
individual scores and mean scores fell below cut-off
score) and for its clinical reliability using the Reliability
Change Index method (RCI) as described by Jacobson
and Truax [35]. This analysis is on data of participants
that completed follow-up at T1 and T2 (i.e. participants
with complete follow-up).
Results
Participants lost to follow-up at the eight months’ screening
were not significantly different from women that were
screened in terms of median age; 27 years old and 28 years
old respectively, in parity (2 children and 1.8 children, re-
spectively, p-value = 0.48) or in educational level (Pearson
chi square p-value = 0.78).
Participants with complete follow-up at T1 and T2 were
223 (74.3% of sample) and 77 participants did not
complete screening either at T1 or at T2 (see Fig. 1).
Mean scores of EPDS at T1 and T2 for the entire sample
were compared with mean scores for the 223 participants.
Differences in mean scores (between 0 and 0.06 points on
a 30-point scale) were insignificant between participants
that had complete follow-up and participants that were
lost at either T1 or T2. Table 1 illustrates the characteris-
tics of women that completed follow-up.
Course of postnatal depression symptoms among women
with “complete follow up”
Twenty participants at three months and eight partici-
pants at eight months tested “positive” by EPDS at a
cut-off score of ≥12 (correlation coefficient = 0.57; p <
0.001). To reflect minor and major depression com-
bined, 26 participants at three months and 10 partici-
pants at eight months scored ≥10 cut-off score. A
paired-samples t-test was conducted on EPDS scores
across T1 and T2. There was a significant reduction of
EPDS mean scores between T1 and T2 (Table 2). A
mixed between-within subjects ANOVA was conducted
to assess the effect of time on depression status. Figure 2
illustrates the change in mean scores over time for EPDS
test “positives” and “negatives” from T1 until T2. There
was a significant interaction between time and depres-
sion status (Wilks’ Lambda = 0.69, F (1,221) =98.9,
p < .0005, partial eta squared = 0.31) meaning that the
change of scores across time was different between de-
pressed and non-depressed mothers. Mothers with de-
pression symptoms at three months were more likely to
recover by eight months. Their mean EPDS score was
15.3 (SD = 3.2) at T1 and 6.7 (SD = 5.7) at T2. There was
56% reduction in mean scores to below the cut-off score
of <12. Non-depressed mothers at three months showed
stable symptomology up to eight months after birth.
The next set of analysis was about EPDS “test posi-
tives” at T1 (20 women) (see Fig. 3). Sixteen out of those
20 women scored below 12 at T2. The Reliable Change
Index Score for each of the 16 was more than 1.96 (two
standard deviations) indicating reliable change. They
constitute the remission group. The remaining four par-
ticipants experienced “continuing depression” The Reli-
able Change Index Score for each was below 1.96
indicating unreliable change (i.e. we are 95% confident
that change in EPDS scores was not real and most likely
due to measurement error). All four “continuing depres-
sion” participants were clinically diagnosed with depres-
sion at T1 by a diagnostic interview and all had
corresponding scores above ≥1.85 by HSCL-10 at both
screening points. Their ages were 23, 26, 27 and 30 years,
Two had a history of domestic violence, one had a per-
ceived history of depression before pregnancy. One par-
ticipant suffered from anemia during pregnancy and all
had term pregnancies. With regard to newborn illness:
one participant had a newborn suffering from a congeni-
tal anomaly. Three participants had primary level educa-
tion and one was a university student.
In addition, four other participants developed new
major depressive symptoms at eight months after
Table 1 Characteristics of women with complete follow-up (n
= 223)
Variable No. (%)
Educational level
University and Postgraduate 89 (39.9%)
Secondary 64 (28.7%)
Primary 65 (29.1%)
No education 5 (2.2%)
Parity
Primigravida 56 (25.1%)
Multigravida(1–4) 147 (65.9%)
Grandmultipara (= > 5) 20 (9%)
Polygamy
Yes 17 (7.6%)
No 206 (92.4%)
Place of delivery
Health Facility 206 (92.4%)
Home 17 (7.6%)
Mode of delivery
Vaginal (incl. abortion) 139 (62.3%)
C/section 84 (37.7%)
History of psychological condition
Yes 18 (8.1%)
No 205 (91.9%)
Family history of a psychological condition
Yes 37(16.6%)
No 186(83.4%)
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delivery (EPDS score was ≥12 at T2). They constitute
the “incident” depression group. Their ages were 28 (2
women), 32 and 37 years. None of them had a history of
domestic violence or of a perceived past psychological
condition. One suffered a stillbirth. Otherwise, their
medical and obstetrical history was unremarkable.
Mothers with new onset symptoms at 8 months seem to
have higher parity compared to mothers with continuing
depression symptoms (the former had two, four, and six
children compared to no children, one and two chil-
dren). Figure 3 illustrates the results of the EPDS across
the two screening points.
The majority of the respondents (89.2%) remained in
the same EPDS category across the two time points (al-
ways scoring <12 in EPDS). In fact, 96.4% of participants
either remained in the same EPDS category, or improved
eight months after birth.
Only three participants diagnosed with clinical depres-
sion by a clinical interview at T1 responded to our refer-
ral to the local psychiatric outpatient clinic and received
appropriate management. One of them was lost to
follow-up at 8 months and the other two participants
scored below 12 at 8 months.
Prevalence of maternal distress by HSCL-10 at the two
screening points
At a cut-off point of ≥1.85, HSCL-10 measured higher dis-
tress among participants than EPDS. At three months
after birth, 30 participants (13.5%) had high distress symp-
toms. At eight months screening (T2) 13participants
(5.8%) had high distress (Table 2). A paired-samples t-test
was performed on HSCL-10 scores on T1 and T2. Mean
scores of HSCL-10 significantly decreased by 8.3% at T2
for all 223 participants (Table 2).
There were strong and positive correlations between
depression and distress at the two screening points
(Table 3). Correlations between EPDS total scores and
the two anxiety and depression subscales of HSCL-10
were similarly positive and significant but stronger at T1
than T2. Higher scores of HSCL-10 are strongly
Fig. 2 Change of mean EPDS scores from T1 until T2
Table 2 Prevalence of depression and distress symptoms at 3 months (T1) and 8 months (T2) postpartum with EPDS and HSCL-10
(n = 223)
Prevalence Mean of scores(SD) Difference of means SD 95% CI P value
EPDS T1a 9.2% 4.37(4.5) 1.83 3.8 1.33–2.33 < 0.001
EPDS T2 3.6% 2.54(3.3)
HSCL-10T1b 13.5% 1.44(0.38) 0.13 0.32 0.08–0.16 < 0.001
HSCL-10 T2 5.8% 1.31(0.28)
aCut-off score ≥ 12/30
bCut-off score ≥ 1.85/4
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associated with higher scores of EPDS, and HSCL-10 ex-
plained almost 60% of the depression symptoms de-
tected by the EPDS in the sample.
Discussion
The study illustrates that depression symptoms can
exist well beyond the early postnatal period on a sub-
set of women. The study also showed a general re-
duction of severity of symptoms for most mothers
further away from birth. The decrease in the level of
depression symptoms was probably not due to active
treatment of clinically diagnosed cases, as very few
proactively sought our referral services. We also
showed that depression at three months constitutes
higher risk and could predict depression later on in
the first postnatal year. These findings were paralleled
by both screening tests: all mothers reporting high
depressive symptoms also showed a similar pattern of
heightened distress Heron et al. [36] assessed the pat-
tern of symptoms in a large community sample in
England (n = 8323) during pregnancy up to 8 months
after birth by self-reporting tools [37]. They reported
a mean decrease in depression and anxiety across the
period. McMahon et al. followed 100 postnatal
mothers in Australia and measured depression symp-
toms by self-reporting tools one year after delivery
[37]. They reported that 30% of all mothers and 60%
of those depressed at 4 months continued to report
significant depression at one year [37]. They also re-
ported on factors predicting the persistence of depres-
sive symptoms. Horowitz et al. [38] followed mothers
that had high depression symptoms when screened 2
Fig. 3 Results of the EPDS screening tests at the two screening points for participants with complete follow-up
Table 3 Correlations between EPDS & HSCL-10 at 3 and
8 months postpartum
Correlation with EPDS P valuea
At T1 (3 months postpartum)
Total HSCL-10 score 0.77 <.001
Depression subscale 0.69
Anxiety subscale 0.67
At T2 (8 months postpartum)
Total HSCL-10 0.78 <.001
Depression subscale 0.59
Anxiety subscale 0.59
aP value is for Pearson correlation coefficient
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to 4 weeks after birth. Two years after birth, 30% of
these mothers continued with depressive symptoms
[38]. Women with a chronic course of depression
were more likely to have suffered from previous de-
pression, have high parental distress and limited
current partner support [38]. Depression symptoms
with atypical time of onset or course have raised the
argument whether symptoms are in fact PND or an
undiagnosed bipolar disorder that was triggered by
the birth experience. Recent studies have explored the
possibility of PND being an indicator for underlying
bipolar depression. Liu et al. [39] conducted a Danish
register-based cohort study and reported that the risk
of bipolar depression among women with postnatal
depression symptoms was higher than in women with
depression outside the first year after birth. Sharma et
al. [40] reported that 21.4–54% of women with PND
in different studies have a diagnosis of bipolar depres-
sion. Having a mood disorder during such sensitive
periods has tremendous impact on the mother, child,
partner, and family. A chronic course of depression
will involve more impairment and role limitations for
depressed mothers. The period during and after preg-
nancy in low resource settings is a time of highest
contact between mothers and healthcare services and
it is a missed opportunity to detect and manage de-
pression symptoms, whether it is unipolar or bipolar.
This article adds to existing research from North Af-
rica by taking a prospective approach, measuring, and
monitoring the course of depression and distress symp-
toms after the customary period for postnatal screening.
This analysis highlights to healthcare personnel that they
should not rule out PND if symptoms occur after the
early postnatal period [41]. Women may not recognize
the symptoms and may not seek help in the immediate
weeks following birth. There are still limits in existing
classifications of postnatal depression by the Diagnostic
and Statistical Manual for Mental disorders (DSM 4 and
5) and in ICD-10 in spite of clear evidence from studies
on late postnatal onset of depression [41–43]. Nonethe-
less, a depression screening strategy should take into ac-
count potential relapse or chronic course of depression
symptoms. Women with relevant risk factors are more
likely to have a consistent level of depression symptoms
throughout the first postnatal year [44]. Hence, it will be
cost-effective, in low resource settings, to redirect re-
peated screening and follow-up care to women at higher
risk of depression, as the number of women may be
small. Low risk mothers will be reached through health
promotion and awareness raising, even if they are not
targeted for repeated screening for depression. That way
they are equipped with knowledge if they do suffer from
symptoms during pregnancy or after birth. To prevent a
chronic course of postnatal depression, it may be
necessary to identify symptoms and risk factors as well
[44]. As our study showed, a negative early screening
test may predict a continued negative test later on and
this reduces the need for repeated screening for all
women.
The study suggests that existing screening tools used
to screen for depression can correlate with tools devel-
oped to detect women at risk for PND, especially in low
resource settings where the possibility of adopting new
tools is difficult. Further studies to compare perform-
ance of HSCL-10 against a diagnostic tool are needed to
optimize cut-off points suitable for the perinatal period.
We also recommend further qualitative studies on why
women are reluctant to respond to referrals to mental
health services.
Our study had several limitations. We relied on
self-reporting instruments, not on clinical interviews, to
measure severity and course of symptoms. In addition,
the study did not investigate onset of depression symp-
toms during pregnancy. We missed the opportunity to
assess if antenatal depression predicted the prevalence
and course of postnatal depression. Due to this limita-
tion, we illustrated our results as new onset late postna-
tal depression. Also, repeated screening by the
investigator may have provided participants with some
supportive talk therapy that could have biased (underes-
timated) our eight months screening results. Studies
have shown that the most desired method of treatment
by women feeling depressed is talking about their feel-
ings with a sympathetic listener who understands the
nature and extent of their feelings [45]. On the other
hand, the concept of repeated screening may have raised
feelings of stigma or intrusion among our respondents.
This may have increased the number of participants who
ignored or refused our second screening, although this
risk was investigated statistically and was proved min-
imal. In addition, we do not consider our estimates
generalizable to all women in Sudan. Our estimates may
underestimate the magnitude of PND among mothers,
for example, in the Eastern and Southern regions of
Sudan, which are states suffering from political unrest
and other psychosocial risk factors.
Conclusion
The ICD-10 and DSM-5 PND onset classification
does not reflect consistent evidence brought about
from longitudinal studies. Hence, postnatal depression
will remain underdiagnosed with consequent policy
implications. Screening strategies should advocate re-
peated screening during the first postnatal year as
symptoms could persist or relapse beyond the early
postnatal period. In low resource settings, repeated
screening could be directed to mothers with relevant
risk factors for depression.
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